These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2872305)

  • 1. In-vitro metabolism of lignocaine to its N-oxide.
    Patterson LH; Hall G; Nijjar BS; Khatra PK; Cowan DA
    J Pharm Pharmacol; 1986 Apr; 38(4):326. PubMed ID: 2872305
    [No Abstract]   [Full Text] [Related]  

  • 2. A new lidocaine metabolite, omega-diethylamino-2-hydroxymethyl-6-methylacetanilide.
    Kawai R; Fujita S; Suzuki T
    Drug Metab Dispos; 1986; 14(2):277-9. PubMed ID: 2870907
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of lignocaine metabolism by beta-adrenoceptor antagonists in rat and human liver microsomes.
    al-Asady SA; Black GL; Lennard MS; Tucker GT; Woods HF
    Xenobiotica; 1989 Sep; 19(9):929-44. PubMed ID: 2573201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of liver carboxylesterases in the in vitro metabolism of lidocaine.
    Alexson SE; Diczfalusy M; Halldin M; Swedmark S
    Drug Metab Dispos; 2002 Jun; 30(6):643-7. PubMed ID: 12019189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precursor-metabolite interaction in the metabolism of lidocaine.
    Suzuki T; Fujita S; Kawai R
    J Pharm Sci; 1984 Jan; 73(1):136-8. PubMed ID: 6694073
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of vesicle lipid composition on the metabolism of lignocaine by a male-specific isozyme of cytochrome P-450 from rat liver.
    Meftah NM; Skett P
    Biochem Pharmacol; 1987 Nov; 36(21):3771-2. PubMed ID: 3675630
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective 3-hydroxylation deficiency of lidocaine and its metabolite in Dark Agouti rats.
    Masubuchi Y; Umeda S; Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1991 Jul; 42(3):693-5. PubMed ID: 1859470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent kinetics of lignocaine in the isolated perfused rat liver.
    Lennard MS; Tucker GT; Woods HF
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):165-82. PubMed ID: 6886972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantitation of lidocaine and its four metabolites by high-performance liquid chromatography: application to studies on in vitro and in vivo metabolism of lidocaine in rats.
    Kawai R; Fujita S; Suzuki T
    J Pharm Sci; 1985 Nov; 74(11):1219-24. PubMed ID: 4087184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the in vitro interaction between lidocaine and premedications using human liver microsomes.
    Nagashima A; Tanaka E; Inomata S; Honda K; Misawa S
    J Clin Pharm Ther; 2005 Apr; 30(2):185-8. PubMed ID: 15811173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of lidocaine metabolism by rat nasal microsomes: implications for nasal drug delivery.
    Deshpande VS; Genter MB; Jung C; Desai PB
    Eur J Drug Metab Pharmacokinet; 1999; 24(2):177-82. PubMed ID: 10510747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes.
    Oda Y; Imaoka S; Nakahira Y; Asada A; Fujimori M; Fujita S; Funae Y
    Biochem Pharmacol; 1989 Dec; 38(24):4439-44. PubMed ID: 2604746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of stobadine, a gamma-carboline antiarrhythmic and cardioprotective agent, in rat liver microsomes.
    Stefek M; Benes L; Jergelová M; Scasnár V; Turi-Nagy L; Kocis P
    Xenobiotica; 1987 Sep; 17(9):1067-73. PubMed ID: 3687063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric identification of an N-oxide formed by incubation of N,N-dimethyl-5H-dibenzo[a,d]cycloheptene-delta5,gamma-propylamine with rat liver microsomes.
    Belvedere G; Rovei V; Pantarotto C; Frigerio A
    Biomed Mass Spectrom; 1974 Oct; 1(5):329-31. PubMed ID: 4465001
    [No Abstract]   [Full Text] [Related]  

  • 15. The yin and yang of lidocaine and cyclosporine metabolism in liver graft recipients.
    Christians U; Kohlhaw K; Esselmann H; Sürig T; Luy M; Kaltefleiter M; Beyrau R; Linck A; Ringe B; Oellerich M
    Transplant Proc; 1994 Oct; 26(5):2827-8. PubMed ID: 7940891
    [No Abstract]   [Full Text] [Related]  

  • 16. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.
    Bargetzi MJ; Aoyama T; Gonzalez FJ; Meyer UA
    Clin Pharmacol Ther; 1989 Nov; 46(5):521-7. PubMed ID: 2582709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of doxophylline by rat liver microsomes.
    Grosa G; Franzone JS; Biglino G
    Drug Metab Dispos; 1986; 14(2):267-70. PubMed ID: 2870905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism in vitro of N-methylamphetamine with rat liver homogenates.
    Coutts RT; Kovach SH
    Biochem Pharmacol; 1977 Jun; 26(11):1043-9. PubMed ID: 18150
    [No Abstract]   [Full Text] [Related]  

  • 19. Extraction and metabolism of lidocaine in rat liver.
    Nyberg G; Karlén B; Hedlund I; Grundin R; von Bahr C
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):337-46. PubMed ID: 576562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of lidocaine by liver microsomes from streptozotocin-diabetic rats.
    Gawrońska-Szklarz B; Musial D; Droździk M; Paprota B
    Pol J Pharmacol; 2003; 55(2):251-4. PubMed ID: 12926555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.